SSX2 and prostate cancer: Upon knockdown of SSX2 in the 22Rv1 prostate cancer cell line we found that the SSX2 knockdown cells had less anchorage-independent growth, faster growth rate, increased invasion, and increased tumorigenicity in SCID mice.